 |
| |
| |
| |
| |
| |
| |
|
| TissGeneSummary for RNF138 |
 Gene summary |
| Basic gene information | Gene symbol | RNF138 |
| Gene name | ring finger protein 138, E3 ubiquitin protein ligase | |
| Synonyms | HSD-4|NARF|STRIN|hNARF | |
| Cytomap | UCSC genome browser: 18q12.1 | |
| Type of gene | protein-coding | |
| RefGenes | NM_001191324.1, NM_016271.4,NM_198128.2, | |
| Description | E3 ubiquitin-protein ligase RNF138NLK-associated RING finger proteinNemo-like kinase-associated RING finger proteinnemo-like kinase associated ring finger protein | |
| Modification date | 20141207 | |
| dbXrefs | HGNC : HGNC | |
| Ensembl : ENSG00000134758 | ||
| HPRD : 11508 | ||
| Vega : OTTHUMG00000132265 | ||
| Protein | UniProt: go to UniProt's Cross Reference DB Table | |
| Expression | CleanEX: HS_RNF138 | |
| BioGPS: 51444 | ||
| Pathway | NCI Pathway Interaction Database: RNF138 | |
| KEGG: RNF138 | ||
| REACTOME: RNF138 | ||
| Pathway Commons: RNF138 | ||
| Context | iHOP: RNF138 | |
| ligand binding site mutation search in PubMed: RNF138 | ||
| UCL Cancer Institute: RNF138 | ||
| Assigned class in TissGDB* | C | |
| Included tissue-specific gene expression resources | TiGER,GTEx | |
| Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx) | Testis | |
| Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA) | TGCT | |
| Reference showing the relevant tissue of RNF138 | ||
| Description by TissGene annotations | Have significant anti-correlated miRNA TissgsLTS Fused withOncogene | |
| * Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C. |
| Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
| GO ID | GO term | PubMed ID |
| Top |
| TissGeneExp for RNF138 |
| Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
 |
| Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01) |
 |
| Gene expressions across normal tissues of GTEx data (GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct) - Here, we shows the matched tissue types only among our 28 cancer types. |
 |
| Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
 |
| - Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05) |
| Cancer type | Mean(exp) in tumor | Mean(exp) in matched normal | Log2FC | P-val. | FDR |
| Top |
| TissGene-miRNA for RNF138 |
| Significantly anti-correlated miRNAs of TissGene across 28 cancer types (Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016) (TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21) (TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16) (Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25)) |
| Cancer type | miRNA id | miRNA accession | P-val. | Coeff. | # samples |
| LUAD | hsa-miR-495-3p | MIMAT0002817 | 0.0092 | -0.34 | 60 |
| Top |
| TissGeneMut for RNF138 |
| TissGeneSNV for RNF138 |
| nsSNV counts per each loci. Different colors of circles represent different cancer types. Circle size denotes number of samples. (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) * Click on the image to enlarge it in a new window. |
 |
 |
| Somatic nucleotide variants of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of mutated samples) The numbers in parentheses are numbers of samples with mutation (nsSNVs). (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) |
 |
| - nsSNVs sorted by frequency. |
| AAchange | Cancer type | # samples |
| p.H36Q | LUAD | 1 |
| p.V37F | CHOL | 1 |
| p.Q183* | BLCA | 1 |
| p.S151Y | UCEC | 1 |
| p.R99K | COAD | 1 |
| p.G198V | LUAD | 1 |
| p.Y219C | COAD | 1 |
| p.V208I | PRAD | 1 |
| p.K81T | COAD | 1 |
| p.S115F | BLCA | 1 |
| p.H101N | STAD | 1 |
| p.P190T | LUAD | 1 |
| p.S141C | LUSC | 1 |
| p.T179A | LUSC | 1 |
| p.P190S | HNSC | 1 |
| p.A236V | OV | 1 |
| p.G84D | LGG | 1 |
| p.V185I | LUAD | 1 |
| p.S240C | LUAD | 1 |
| p.S116F | STAD | 1 |
| p.I78T | LGG | 1 |
| p.Q269K | KIRP | 1 |
| p.S115C | BLCA | 1 |
| p.R58H | BRCA | 1 |
| p.Q232K | SARC | 1 |
| p.A52T | UCEC | 1 |
| p.Y108H | STAD | 1 |
| p.E239* | UCEC | 1 |
| p.R214I | READ | 1 |
| p.R171C | UCEC | 1 |
| Top |
| TissGeneCNV for RNF138 |
| Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples) (TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16) |
 |
| Top |
| TissGeneFusions for RNF138 |
| Fusion genes including TissGene (ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01) |
| Database | Src | Cancer type | Sample | Fusion gene | ORF | 5'-gene BP | 3'-gene BP |
| Chimerdb3.0 | FusionScan | SARC | TCGA-DX-A1L3-01A | RNF138-RAP1B | Out-of-Frame | chr18:29672849 | chr12:69050085 |
| TCGAfusionPortal | PRADA | BRCA | TCGA-C8-A1HN-01A | RNF138-RNF125 | Out-of-frame | Chr18:29672849 | Chr18:29648261 |
| TCGAfusionPortal | PRADA | LUAD | TCGA-86-8673-01A | RNF138-RNF125 | Out-of-frame | Chr18:29672849 | Chr18:29645865 |
| TCGAfusionPortal | PRADA | THCA | TCGA-CE-A484-01A | RNF138-RNF125 | Out-of-frame | Chr18:29672849 | Chr18:29648261 |
| Top |
| TissGeneNet for RNF138 |
| Co-expressed gene networks based on protein-protein interaction data (CePIN) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (PINA2 ppi data) |
| BRCA (tumor) | BRCA (normal) |
| RNF138, UBE2W, COPS6, UBE2D2, ELAVL1, QKI, COPS5, LNX2, TCF4, TAF9, UBE2D4, UBE2K, TRIM8, PCBP4, C6orf165 (tumor) | RNF138, UBE2W, COPS6, UBE2D2, ELAVL1, QKI, COPS5, LNX2, TCF4, TAF9, UBE2D4, UBE2K, TRIM8, PCBP4, C6orf165 (normal) |
 |  |
| COAD (tumor) | COAD (normal) |
| RNF138, UBE2W, COPS6, UBE2D2, ELAVL1, QKI, COPS5, LNX2, TCF4, TAF9, UBE2D4, UBE2K, TRIM8, PCBP4, C6orf165 (tumor) | RNF138, UBE2W, COPS6, UBE2D2, ELAVL1, QKI, COPS5, LNX2, TCF4, TAF9, UBE2D4, UBE2K, TRIM8, PCBP4, C6orf165 (normal) |
 |  |
| HNSC (tumor) | HNSC (normal) |
| RNF138, UBE2W, COPS6, UBE2D2, ELAVL1, QKI, COPS5, LNX2, TCF4, TAF9, UBE2D4, UBE2K, TRIM8, PCBP4, C6orf165 (tumor) | RNF138, UBE2W, COPS6, UBE2D2, ELAVL1, QKI, COPS5, LNX2, TCF4, TAF9, UBE2D4, UBE2K, TRIM8, PCBP4, C6orf165 (normal) |
 |  |
| KICH (tumor) | KICH (normal) |
| RNF138, UBE2W, COPS6, UBE2D2, ELAVL1, QKI, COPS5, LNX2, TCF4, TAF9, UBE2D4, UBE2K, TRIM8, PCBP4, C6orf165 (tumor) | RNF138, UBE2W, COPS6, UBE2D2, ELAVL1, QKI, COPS5, LNX2, TCF4, TAF9, UBE2D4, UBE2K, TRIM8, PCBP4, C6orf165 (normal) |
 |  |
| KIRC (tumor) | KIRC (normal) |
| RNF138, UBE2W, COPS6, UBE2D2, ELAVL1, QKI, COPS5, LNX2, TCF4, TAF9, UBE2D4, UBE2K, TRIM8, PCBP4, C6orf165 (tumor) | RNF138, UBE2W, COPS6, UBE2D2, ELAVL1, QKI, COPS5, LNX2, TCF4, TAF9, UBE2D4, UBE2K, TRIM8, PCBP4, C6orf165 (normal) |
 |  |
| KIRP (tumor) | KIRP (normal) |
| RNF138, UBE2W, COPS6, UBE2D2, ELAVL1, QKI, COPS5, LNX2, TCF4, TAF9, UBE2D4, UBE2K, TRIM8, PCBP4, C6orf165 (tumor) | RNF138, UBE2W, COPS6, UBE2D2, ELAVL1, QKI, COPS5, LNX2, TCF4, TAF9, UBE2D4, UBE2K, TRIM8, PCBP4, C6orf165 (normal) |
 |  |
| LIHC (tumor) | LIHC (normal) |
| RNF138, UBE2W, COPS6, UBE2D2, ELAVL1, QKI, COPS5, LNX2, TCF4, TAF9, UBE2D4, UBE2K, TRIM8, PCBP4, C6orf165 (tumor) | RNF138, UBE2W, COPS6, UBE2D2, ELAVL1, QKI, COPS5, LNX2, TCF4, TAF9, UBE2D4, UBE2K, TRIM8, PCBP4, C6orf165 (normal) |
 |  |
| LUAD (tumor) | LUAD (normal) |
| RNF138, UBE2W, COPS6, UBE2D2, ELAVL1, QKI, COPS5, LNX2, TCF4, TAF9, UBE2D4, UBE2K, TRIM8, PCBP4, C6orf165 (tumor) | RNF138, UBE2W, COPS6, UBE2D2, ELAVL1, QKI, COPS5, LNX2, TCF4, TAF9, UBE2D4, UBE2K, TRIM8, PCBP4, C6orf165 (normal) |
 |  |
| LUSC (tumor) | LUSC (normal) |
| RNF138, UBE2W, COPS6, UBE2D2, ELAVL1, QKI, COPS5, LNX2, TCF4, TAF9, UBE2D4, UBE2K, TRIM8, PCBP4, C6orf165 (tumor) | RNF138, UBE2W, COPS6, UBE2D2, ELAVL1, QKI, COPS5, LNX2, TCF4, TAF9, UBE2D4, UBE2K, TRIM8, PCBP4, C6orf165 (normal) |
 |  |
| PRAD (tumor) | PRAD (normal) |
| RNF138, UBE2W, COPS6, UBE2D2, ELAVL1, QKI, COPS5, LNX2, TCF4, TAF9, UBE2D4, UBE2K, TRIM8, PCBP4, C6orf165 (tumor) | RNF138, UBE2W, COPS6, UBE2D2, ELAVL1, QKI, COPS5, LNX2, TCF4, TAF9, UBE2D4, UBE2K, TRIM8, PCBP4, C6orf165 (normal) |
 |  |
| STAD (tumor) | STAD (normal) |
| RNF138, UBE2W, COPS6, UBE2D2, ELAVL1, QKI, COPS5, LNX2, TCF4, TAF9, UBE2D4, UBE2K, TRIM8, PCBP4, C6orf165 (tumor) | RNF138, UBE2W, COPS6, UBE2D2, ELAVL1, QKI, COPS5, LNX2, TCF4, TAF9, UBE2D4, UBE2K, TRIM8, PCBP4, C6orf165 (normal) |
 |  |
| THCA (tumor) | THCA (normal) |
| RNF138, UBE2W, COPS6, UBE2D2, ELAVL1, QKI, COPS5, LNX2, TCF4, TAF9, UBE2D4, UBE2K, TRIM8, PCBP4, C6orf165 (tumor) | RNF138, UBE2W, COPS6, UBE2D2, ELAVL1, QKI, COPS5, LNX2, TCF4, TAF9, UBE2D4, UBE2K, TRIM8, PCBP4, C6orf165 (normal) |
 |  |
| Top |
| TissGeneProg for RNF138 |
| Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image to enlarge it in a new window. |
 |
| Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
 |
| Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
 |
| Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
 |
| Top |
| TissGeneClin for RNF138 |
| TissGeneDrug for RNF138 |
| Drug information targeting TissGene (DrugBank Version 5.0.6, 2017-04-01) |
| DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
| Top |
| TissGeneDisease for RNF138 |
| Disease information associated with TissGene (DisGeNet, 2016-06-01) |
| Disease ID | Disease name | # pubmeds | Source |
| umls:C0017661 | IGA Glomerulonephritis | 1 | CTD_human |
| umls:C0040336 | Tobacco Use Disorder | 1 | GAD |
Copyright 2016-Present - The University of Texas Health Science Center at Houston (UTHealth) Web File Viewing | How to Report, Fraud, Waste and Abuse | State of Texas | Statewide Search | Texas Homeland Security | Site Policies |